Author:
Netzer Nikolaus C.,Küpper T.,Voss Hans W.,Eliasson Arn H.
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Otorhinolaryngology
Reference65 articles.
1. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program, Expert Panel Report 3: guidelines for the diagnosis and management of asthma. National Institutes of Health pub no 07-4051. Bethesda, MD, 2007
2. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF (1992) Effects of 22 months of treatment with inhaled steroids and/or beta2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 146:547–554
3. Haahtela T, Jarvinen M, Kava T, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O (1991) Comparison of a beta2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 325:388–392
4. Leflein JG, Szefler SJ, Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, Smith JA (2002) Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial. Pediatrics 109:866–872
5. Turpeinen M, Pelkonen AS, Nikander K, Sorva R, Selroos O, Juntunen-Backman K, Haahtela T (2010) Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study. Pediatr Res 68:169–173
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献